TGA Approval

PRAXBIND idarucizumab (rch) 50 mg/ml solution for injection/infusion vial (237761)

ARTG ID

237761

ARTG Name

PRAXBIND idarucizumab (rch) 50 mg/ml solution for injection/infusion vial

Sponsor

Boehringer Ingelheim Pty Ltd

ARTG Date

May 11, 2016

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

BOEHRINGER INGELHEIM PTY LTD

https://medical-cdn.nocode.com/drug_tga/69645d6777c0c09b8cc0eb43a5a820cc.pdf

https://medical-cdn.nocode.com/drug_tga/1ba26131b8de404d6095a0b0ffca5fc5.pdf

Ingredient Name

idarucizumab

Empowering clinical research with data-driven insights and AI-powered tools.

PRAXBIND idarucizumab (rch) 50 mg/ml solution for injection/infusion vial (237761) - TGA 批准文号 | MedPath